In the Pipeline
Phần mềm chống xóc đĩa trên điện thoại di độngOur pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients.
Our Pipeline at a Glance
As of November 17, 2020
Compounds in Development
Disease Areas Being Studied
Like any other scientific endeavor, clinical testing of novel drug compounds is a complex, time-consuming, resource-intensive process with no guaranteed results. But, as described here, Bristol Myers Squibb is committed to pursuing such clinical development and, in doing so, to bringing new hope to patients.
In the Pipeline Download Pipeline
Phần mềm chống xóc đĩa trên điện thoại di độngThe safety and efficacy of investigational agents and/or investigational uses of approved products have not been established.
For information on approved uses, refer to approved product labeling.Phase I - clinical trials investigating safety of an investigational medicine in a small number of human subjects. Phase II - clinical trials investigating dosing, safety and efficacy of an investigational medicine in a small number of patients who have the disease or condition under study.Phase III - clinical trials investigating the safety and efficacy of an investigational medicine in a larger number of patients who have the disease or condition under study. For purposes of this chart, this includes the regulatory approval process prior to receiving marketing approval in the first major market.